According to the Zhitong Finance APP, Chanhen (002895.SZ) released its 2024 annual report, showing an operating income of 5.906 billion yuan, a year-on-year increase of 36.72%. The net profit attributable to shareholders of the listed company was 956 million yuan, a year-on-year increase of 24.80%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 936 million yuan, a year-on-year increase of 23.01%. The basic earnings per share were 1.7647 yuan. In addition, it plans to distribute a cash dividend of 12 yuan (including tax) for every 10 shares to all shareholders.

In 2024, the operating income from phosphoric acid and feed-grade dicalcium phosphate reached 3.317 billion yuan, setting a historical high; the operating income from monoammonium phosphate was 1.176 billion yuan, a year-on-year increase of 19.91%; mainly benefiting from the production launch of the subsidiary Guangxi Pengyue's "200,000 tons/year semi-hydrate and dihydrate wet-process phosphoric acid and deep processing" project, which significantly boosted product sales through capacity release